AI in Healthcare Series: You Can’t Delegate AI with Andy Slavitt

| Podcasts | January 29, 2026 | 3.85 Thousand views | 39:41

TL;DR

Andy Slavitt and Stanford experts discuss how AI adoption in healthcare is accelerating faster than organizational readiness, creating a critical imperative for leaders to personally engage with the technology while new CMS payment models and FDA pathways signal a policy shift toward rapid AI integration and patient empowerment.

🎯 The "Don't Delegate AI" Mandate 2 insights

Leaders must personally engage with evolving tools

Slavitt warns that AI capabilities change too rapidly for executives to delegate understanding to IT teams; leaders dismissing AI based on two-year-old experiences with ChatGPT hallucinations are making decisions on obsolete technology.

Hire dedicated talent to maintain currency

Town Hall Ventures hired a full-time AI research fellow solely to keep the investment team at the cutting edge, acknowledging they "can't sound smart at something they read about" and must use the tools daily to evaluate opportunities.

⚠️ The Healthcare Adoption Disconnect 2 insights

Physicians adopt AI despite organizational barriers

Survey data reveals 67% of physicians use AI daily, yet 81% are dissatisfied with their organization's approach, with 71% having no influence over tool selection and 48% rating employer AI communication as poor.

Bottom-up pressure meets restrictive policies

Unlike previous healthcare technologies requiring change management "push," clinicians are "pulling" AI through personal devices, creating a "red alert" situation where health systems risk irrelevance by restricting rather than empowering usage.

🏛️ Policy Signals and Payment Innovation 2 insights

CMS Access Model shifts payment to technology outcomes

The new CMS model pays technology companies—not just physicians—when AI tools demonstrate measurable improvements in patient health, representing the strongest policy signal yet for rapid deployment and outcomes-based validation.

FDA creates fast-track approval pathway

The FDA established a separate review process allowing AI tools to bypass traditional long-term safety studies, while the administration actively promotes adoption through Treasury dollars rather than merely preventing state-level regulations.

👥 Patient Empowerment and Access Transformation 2 insights

Consumers rapidly closing the information gap

Comfort with "AI doctors" jumped from 11% to 28% in one year, with patients creating personal health LLMs containing complete lab histories to prepare for visits, fundamentally reducing traditional physician-patient information asymmetry.

Rural access becomes transformative necessity

For rural patients facing nine-week specialist waits, AI represents essential infrastructure rather than convenience, providing 24/7 access to guidance that exceeds traditional physician text relationships and addresses critical care gaps.

Bottom Line

Healthcare leaders must immediately shift from trying to 'tame' AI through restrictive policies to actively 'riding' it by personally using the tools, empowering clinical adoption, and preparing for patients who arrive with AI-generated health insights.

More from Stanford Online

View all
Stanford CS153 Frontier Systems | Andreas Blattmann from Black Forest Labs on Visual Intelligence
1:01:14
Stanford Online Stanford Online

Stanford CS153 Frontier Systems | Andreas Blattmann from Black Forest Labs on Visual Intelligence

Andreas Blattmann, co-founder of Black Forest Labs and co-creator of Stable Diffusion, argues that visual intelligence represents the critical next frontier for AI, requiring a fundamental shift from text-centric unimodal models to multimodal systems trained on 'natural representations' (video, audio, physics) to unlock true reasoning, robotics capabilities, and higher intelligence.

5 days ago · 9 points